{"pub": "morningstar", "url": "https://morningstar.com/news/dow-jones/201910238085/eli-lilly-shares-decline-after-co-reported-revenue-miss", "downloaded_at": "2019-10-23 15:00:53.618805+00:00", "title": "Eli Lilly Shares Decline After Co. Reported Revenue Miss", "language": "en", "text": "By Dave Sebastian\n\nEli Lilly & Co. (LLY) shares fell about 5% to $104.30 Wednesday after the company earlier in the day reported third-quarter results.\n\nThe pharmaceutical company reported revenue of $5.48 billion, missing the $5.5 billion analysts polled by FactSet had expected. The company posted $5.31 billion in revenue a year earlier.\n\nNet income for the quarter was $1.25 billion, or $1.37 a share, compared with $1.15 billion, or $1.12 a share, in the comparable quarter last year.\n\nOn an adjusted basis, earnings were $1.48 a share, beating the $1.40 a share analysts polled by FactSet had expected. The company posted $1.34 a share in adjusted earnings in the year-earlier period.\n\nWrite to Dave Sebastian at dave.sebastian@wsj.com\n\n(END) Dow Jones Newswires\n\nOctober 23, 2019 10:39 ET (14:39 GMT)\n\nCopyright (c) 2019 Dow Jones & Company, Inc.", "description": "", "authors": [], "top_image": "https://morningstar.com/assets/img/30241a1.png", "published_at": "2019-10-23"}